Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 17 · 1 feed behind: Insider filings, 10 days · Every feed →

All 7,309Congress 2,157Executive branch 468Insiders 4,684
AllBuysSells
Filed late
More filters
DemRepInd
HouseSenateExecutive
$15K+$50K+$100K+$250K+$1M+
Clear filters

Insiders · filed late · 4,684 trades

Trades
4,684
Buys 1,074 · Sells 3,610
People
1,192
Stocks
723
Disclosed value
$7.6B
range midpoints · Congress & executive
Filed late
4,684
  1. ▲ BUYVivo Opportunity Fund Holdings, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$9.6Kdisclosed Jun 10 · filed 6 days after the trade · late
  2. ▲ BUYVivo Opportunity Fund Holdings, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$7.9Kdisclosed Jun 10 · filed 5 days after the trade · late
  3. ▲ BUYJack Jiajia Huang Chief Executive OfficerCOE 51Talk Online Education Group$334Kdisclosed Jun 10 · filed 5 days after the trade · late
  4. ▲ BUYVivo Opportunity, LLC 10% ownerINM InMed Pharmaceuticals Inc.$8Kdisclosed Jun 10 · filed 21 days after the trade · late
  5. ▼ SELLPeter A Leidel DirectorMETC Ramaco Resources, Inc.$35Kdisclosed Jun 10 · filed 78 days after the trade · late
  6. ▲ BUYVivo Opportunity Cayman, LLC 10% ownerINM InMed Pharmaceuticals Inc.$970disclosed Jun 10 · filed 6 days after the trade · late
  7. ▼ SELLPeter A Leidel DirectorMETC Ramaco Resources, Inc.$747Kdisclosed Jun 10 · filed 78 days after the trade · late
  8. ▲ BUYVivo Opportunity Cayman Fund, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$78.4Kdisclosed Jun 10 · filed 5 days after the trade · late
  9. ▲ BUYVivo Opportunity Fund Holdings, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$79.6Kdisclosed Jun 10 · filed 21 days after the trade · late
  10. ▼ SELLMatthew Wein InsiderMGX Metagenomi Therapeutics, Inc.$725disclosed Jun 10 · filed 5 days after the trade · late
  11. ▼ SELLPeter A Leidel DirectorMETC Ramaco Resources, Inc.$23.4Kdisclosed Jun 10 · filed 72 days after the trade · late
  12. ▼ SELLPeter A Leidel DirectorMETC Ramaco Resources, Inc.$722Kdisclosed Jun 10 · filed 79 days after the trade · late
  13. ▲ BUYVivo Opportunity Cayman, LLC 10% ownerINM InMed Pharmaceuticals Inc.$2.3Kdisclosed Jun 10 · filed 9 days after the trade · late
  14. ▼ SELLPeter A Leidel DirectorMETC Ramaco Resources, Inc.$1.1Mdisclosed Jun 10 · filed 79 days after the trade · late
  15. ▼ SELLPamela Wapnick Chief Financial OfficerMGX Metagenomi Therapeutics, Inc.$3.7Kdisclosed Jun 10 · filed 5 days after the trade · late
  16. ▲ BUYVivo Opportunity Fund Holdings, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$1.1Kdisclosed Jun 10 · filed 7 days after the trade · late
  17. ▼ SELLPeter A Leidel DirectorMETC Ramaco Resources, Inc.$1.1Mdisclosed Jun 10 · filed 77 days after the trade · late
  18. ▲ BUYVivo Opportunity, LLC 10% ownerINM InMed Pharmaceuticals Inc.$31.5Kdisclosed Jun 10 · filed 8 days after the trade · late
  19. ▼ SELLPeter A Leidel DirectorMETC Ramaco Resources, Inc.$938Kdisclosed Jun 10 · filed 85 days after the trade · late
  20. ▲ BUYVivo Opportunity Cayman, LLC 10% ownerINM InMed Pharmaceuticals Inc.$25.4Kdisclosed Jun 10 · filed 12 days after the trade · late
  21. ▲ BUYVivo Opportunity Cayman, LLC 10% ownerINM InMed Pharmaceuticals Inc.$78.4Kdisclosed Jun 10 · filed 5 days after the trade · late
  22. ▲ BUYVivo Opportunity, LLC 10% ownerINM InMed Pharmaceuticals Inc.$78.4Kdisclosed Jun 10 · filed 5 days after the trade · late
  23. ▲ BUYJack Jiajia Huang Chief Executive OfficerCOE 51Talk Online Education Group$219Kdisclosed Jun 10 · filed 7 days after the trade · late
  24. ▲ BUYVivo Opportunity Cayman, LLC 10% ownerINM InMed Pharmaceuticals Inc.$7.9Kdisclosed Jun 10 · filed 5 days after the trade · late
  25. ▲ BUYVivo Opportunity, LLC 10% ownerINM InMed Pharmaceuticals Inc.$2.3Kdisclosed Jun 10 · filed 9 days after the trade · late